Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection
about
Microvascular injury after lung transplantationContribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
P2860
Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@ast
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@en
type
label
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@ast
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@en
prefLabel
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@ast
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@en
P2093
P2860
P356
P1476
Cyclosporine Does Not Prevent ...... rfusion During Acute Rejection
@en
P2093
M R Nicolls
M Rabinovitch
N P Nickel
T T Nguyen
V de Jesus Perez
P2860
P304
P356
10.1111/AJT.13189
P407
P577
2015-02-27T00:00:00Z